433 related articles for article (PubMed ID: 19095768)
1. Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.
De Bosscher K; Haegeman G
Mol Endocrinol; 2009 Mar; 23(3):281-91. PubMed ID: 19095768
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids.
Spies CM; Strehl C; van der Goes MC; Bijlsma JW; Buttgereit F
Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):891-900. PubMed ID: 22265268
[TBL] [Abstract][Full Text] [Related]
3. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
Hapgood JP; Avenant C; Moliki JM
Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Mechanisms of Glucocorticoids.
Vandewalle J; Luypaert A; De Bosscher K; Libert C
Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in the side effects of glucocorticoids.
Schäcke H; Döcke WD; Asadullah K
Pharmacol Ther; 2002 Oct; 96(1):23-43. PubMed ID: 12441176
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice.
Kleiman A; Tuckermann JP
Mol Cell Endocrinol; 2007 Sep; 275(1-2):98-108. PubMed ID: 17587493
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.
Beck IM; Vanden Berghe W; Vermeulen L; Yamamoto KR; Haegeman G; De Bosscher K
Endocr Rev; 2009 Dec; 30(7):830-82. PubMed ID: 19890091
[TBL] [Abstract][Full Text] [Related]
9. Dissociated glucocorticoid receptor ligands.
Schäcke H; Rehwinkel H
Curr Opin Investig Drugs; 2004 May; 5(5):524-8. PubMed ID: 15202726
[TBL] [Abstract][Full Text] [Related]
10. Optimized glucocorticoid therapy: teaching old drugs new tricks.
Strehl C; Buttgereit F
Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
[TBL] [Abstract][Full Text] [Related]
11. [The mechanism of glucocorticoid resistance in multiple sclerosis].
Rzazewska-Makosa B
Postepy Hig Med Dosw (Online); 2005 Sep; 59():457-63. PubMed ID: 16177666
[TBL] [Abstract][Full Text] [Related]
12. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
13. New insights into the novel anti-inflammatory mode of action of glucocorticoids.
Ingawale DK; Mandlik SK
Immunopharmacol Immunotoxicol; 2020 Apr; 42(2):59-73. PubMed ID: 32070175
[TBL] [Abstract][Full Text] [Related]
14. Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds.
Sundahl N; Bridelance J; Libert C; De Bosscher K; Beck IM
Pharmacol Ther; 2015 Aug; 152():28-41. PubMed ID: 25958032
[TBL] [Abstract][Full Text] [Related]
15. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
Ayroldi E; Macchiarulo A; Riccardi C
FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
[TBL] [Abstract][Full Text] [Related]
16. The search for safer glucocorticoid receptor ligands.
Rosen J; Miner JN
Endocr Rev; 2005 May; 26(3):452-64. PubMed ID: 15814846
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
[TBL] [Abstract][Full Text] [Related]
18. SEGRAs: a novel class of anti-inflammatory compounds.
Schäcke H; Hennekes H; Schottelius A; Jaroch S; Lehmann M; Schmees N; Rehwinkel H; Asadullah K
Ernst Schering Res Found Workshop; 2002; (40):357-71. PubMed ID: 12355726
[TBL] [Abstract][Full Text] [Related]
19. Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile.
Miner JN; Ardecky B; Benbatoul K; Griffiths K; Larson CJ; Mais DE; Marschke K; Rosen J; Vajda E; Zhi L; Negro-Vilar A
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19244-9. PubMed ID: 18032610
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity.
Belvisi MG; Wicks SL; Battram CH; Bottoms SE; Redford JE; Woodman P; Brown TJ; Webber SE; Foster ML
J Immunol; 2001 Feb; 166(3):1975-82. PubMed ID: 11160246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
